137 related articles for article (PubMed ID: 16960419)
1. 18F-fluorodeoxyglucose positron emission tomography in a case of retroperitoneal fibrosis.
Sakamoto A; Okamoto K; Ishizaka N; Tejima K; Hirata Y; Nagai R
Int Heart J; 2006 Jul; 47(4):645-50. PubMed ID: 16960419
[TBL] [Abstract][Full Text] [Related]
2. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
[TBL] [Abstract][Full Text] [Related]
3. [
Fernando A; Pattison J; Horsfield C; D'Cruz D; Cook G; O'Brien T
Eur Urol; 2017 Jun; 71(6):926-933. PubMed ID: 27876167
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
[TBL] [Abstract][Full Text] [Related]
5. Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings.
Drieskens O; Blockmans D; Van den Bruel A; Mortelmans L
Clin Nucl Med; 2002 Jun; 27(6):413-5. PubMed ID: 12045432
[TBL] [Abstract][Full Text] [Related]
6. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
Pipitone N; Versari A; Vaglio A; Salvarani C
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
[TBL] [Abstract][Full Text] [Related]
7. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
Nemec P; Rehák Z; Fabián P; Soucek M
Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
9. The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
Tatoglu MT; Uslu H; Ibisoglu E
Nuklearmedizin; 2021 Oct; 60(5):381-382. PubMed ID: 33836552
[No Abstract] [Full Text] [Related]
10. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis.
Vaglio A; Versari A; Fraternali A; Ferrozzi F; Salvarani C; Buzio C
Arthritis Rheum; 2005 Feb; 53(1):122-5. PubMed ID: 15696564
[No Abstract] [Full Text] [Related]
11. [
Accorsi Buttini E; Maritati F; Vaglio A
Eur Urol; 2018 Jan; 73(1):145-146. PubMed ID: 29033102
[No Abstract] [Full Text] [Related]
12. Retroperitoneal fibrosis with duodenal stenosis.
Jun BM; Lee EY; Yoon YJ; Kim EK; Ahn MS; Lee CK; Cho YS; Yoo B; Moon HB
J Korean Med Sci; 2001 Jun; 16(3):371-4. PubMed ID: 11410704
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET in Ormond disease in a patient with renal cell carcinoma.
Agrawal A; Nair N; Baghel N
Clin Nucl Med; 2007 Apr; 32(4):320-2. PubMed ID: 17413587
[No Abstract] [Full Text] [Related]
14. Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm.
Wiggermann P; Aust D; Stroszczynski C; Kotzerke J; Zöphel K
Nuklearmedizin; 2011; 50(3):N21-2. PubMed ID: 21611677
[No Abstract] [Full Text] [Related]
15. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
Young PM; Peterson JJ; Calamia KT
Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
[TBL] [Abstract][Full Text] [Related]
16. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
[TBL] [Abstract][Full Text] [Related]
17. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hyalinizing granuloma and retroperitoneal fibrosis in an adolescent.
Young AS; Binkovitz LA; Adler BH; Nicol KK; Rennebohm RM
Pediatr Radiol; 2007 Jan; 37(1):91-5. PubMed ID: 17061085
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [
Moreau A; Giraudet AL; Mognetti T; Kryza D
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1758-1759. PubMed ID: 31093709
[No Abstract] [Full Text] [Related]
20. Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG).
Kotani S; Wakamatsu R; Itoh A; Miyamoto K; Yoshino M; Takami K; Ishihara S; Miura N; Banno S; Imai H
Intern Med; 2012; 51(7):755-8. PubMed ID: 22466833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
